Rodrigues, Tiago, Bernardes, Gonçalo J. L. (2018) Development of Antibody-Directed Therapies: Quo Vadis ?. Angewandte Chemie International Edition, 57 (8). 2032-2034 doi:10.1002/anie.201712185
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Development of Antibody-Directed Therapies: Quo Vadis ? | ||
Journal | Angewandte Chemie International Edition | ||
Authors | Rodrigues, Tiago | Author | |
Bernardes, Gonçalo J. L. | Author | ||
Year | 2018 (February 19) | Volume | 57 |
Issue | 8 | ||
Publisher | Wiley | ||
DOI | doi:10.1002/anie.201712185Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 8647568 | Long-form Identifier | mindat:1:5:8647568:2 |
GUID | 0 | ||
Full Reference | Rodrigues, Tiago, Bernardes, Gonçalo J. L. (2018) Development of Antibody-Directed Therapies: Quo Vadis ?. Angewandte Chemie International Edition, 57 (8). 2032-2034 doi:10.1002/anie.201712185 | ||
Plain Text | Rodrigues, Tiago, Bernardes, Gonçalo J. L. (2018) Development of Antibody-Directed Therapies: Quo Vadis ?. Angewandte Chemie International Edition, 57 (8). 2032-2034 doi:10.1002/anie.201712185 | ||
In | (2018, February) Angewandte Chemie International Edition Vol. 57 (8) Wiley |
See Also
These are possibly similar items as determined by title/reference text matching only.